Drugs News and Research

RSS

Pain control in osteoarthritis patients

Osteoarthritis (OA) is one of the most common causes of disability, and inadequate pain control can lead to joint stiffness that may impair mobility for patients.

9 Jul 2014

First Edition: June 9, 2014

Today's headlines include a status report on GOP discussions and debate over plans to replace the health law as well as coverage of emerging legislation to override the Supreme Court's Hobby Lobby decision.

9 Jul 2014

Scientists find a new strategy for brain cancer treatment

Scientists at the Montreal Neurological Institute and Hospital, McGill University and McGill University Health Centre have shown that a member of the protein family known as SUMO (small ubiquitin-like modifier) is a key to why tumour cells multiply uncontrollably, especially in the case of glioblastoma. T

9 Jul 2014

New gene therapy may be effective for fighting fungal infections in cancer patients

Sleeping Beauty and fungal infections - not two items one would normally associate together, but for immunocompromised cancer patients they may prove to be a helpful combination.

9 Jul 2014

Research finding offers potential therapeutic avenues for glioblastoma

Invading glioblastoma cells may hijack cerebral blood vessels during early stages of disease progression and damage the brain's protective barrier, a study in mice indicates. This finding could ultimately lead to new ways to bring about the death of the tumor, as therapies may be able to reach these deadly cells at an earlier time point than was previously thought possible.

9 Jul 2014

Scientists reveal structure of protein complex involved in liver and colon cancers

A group of scientists from Spain, the UK and the United States has revealed the structure of a protein complex involved in liver and colon cancers. Both of these types of cancer are of significant social and clinical relevance as in 2012 alone, liver cancer was responsible for the second highest mortality rate worldwide, with colon cancer appearing third in the list.

9 Jul 2014

Study gives parents, doctors new options to treat children with eczema

The number of children with atopic dermatitis, often referred to as eczema, is on the rise. Some estimate that one in five children in the U.S. now suffers from the painful, itchy skin condition. In an effort to control their symptoms, many children are prescribed powerful medications like immunosuppressants or topical steroids.

9 Jul 2014

Scientists release recommendations for evaluating pharmacological safety of oligonucleotide therapeutics

Novel oligonucleotide-based drugs in development offer promising alternatives for treating a range of diseases.

8 Jul 2014

Skin cells possess olfactory receptor for sandalwood scent

Skin cells possess an olfactory receptor for sandalwood scent, as researchers at the Ruhr-Universit-t Bochum have discovered.

8 Jul 2014

Use of performance enhancing drugs unmonitored in young elite athletes

The use of performance enhancing drugs is prevalent and unmonitored in junior elite athletes as young as 12, according to research by Griffith University and the University of Canberra that will be presented tomorrow.

8 Jul 2014

RD Biomed announces Chinese distribution agreement for reflux diagnostic tool Peptest

RD Biomed, the Yorkshire medical technology company, has announced a Chinese distribution agreement for its world-leading reflux diagnostic tool Peptest.

8 Jul 2014

First Edition: July 8, 2014

Today's headlines include reports that a federal judge in Wisconsin heard arguments in a health law challenge brought by a U.S. senator.

8 Jul 2014

Hypertension does not respond to therapy due to inadequate diagnosis

High blood pressure—also known as hypertension—is widespread, but treatment often fails. One in five people with hypertension does not respond to therapy. This is frequently due to inadequate diagnosis, as Franz Weber and Manfred Anlauf point out in the current issue of Deutsches Ärzteblatt International.

8 Jul 2014

New mechanism of chemotherapy resistance in triple-negative inflammatory breast cancer

Researchers at Roswell Park Cancer Institute (RPCI) have identified a mechanism of breast cancer cells that leads to chemotherapy resistance in inflammatory breast cancer.

8 Jul 2014

Alcohol ads can encourage kids to drink

The brands of alcohol popular with underage drinkers also happen to be the ones heavily advertised in magazines that young people read, a new study finds.

8 Jul 2014

Teen dating takes violent turn for nearly 1 in 6 young people

Dating during the teen years takes a violent turn for nearly 1 in 6 young people, a new study finds, with both genders reporting acts like punching, pulling hair, shoving, and throwing things.

8 Jul 2014

Reaction Biology awarded Phase I SBIR grant to create epigenetic database

Reaction Biology Corporation announced today that it has been awarded a Phase I SBIR grant from the National Center for Advancing Translational Sciences to create a database of epigenetic drug interactions.

8 Jul 2014

CWRU receives $12.6 million from NIA to identify rare genetic variants that contribute to Alzheimer's

Researchers from Case Western Reserve University School of Medicine are part of a five-university collaboration receiving a $12.6 million, four-year grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to identify rare genetic variants that may either protect against, or contribute to Alzheimer's disease risk.

8 Jul 2014

Sleep deprivation can lead a healthy person to display symptoms similar to schizophrenia

Twenty-four hours of sleep deprivation can lead to conditions in healthy persons similar to the symptoms of schizophrenia. This discovery was made by an international team of researchers under the guidance of the University of Bonn and King's College London.

7 Jul 2014

$FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL$

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

Novartis announced today that the United States Food and Drug Administration has granted Breakthrough Therapy status to CTL019, an investigational chimeric antigen receptor (CAR) therapy for the treatment of pediatric and adult patients with relapsed/refractory acute lymphoblastic leukemia (r/r ALL).

7 Jul 2014

Drugs News and Research

Pain control in osteoarthritis patients

First Edition: June 9, 2014

Scientists find a new strategy for brain cancer treatment

New gene therapy may be effective for fighting fungal infections in cancer patients

Research finding offers potential therapeutic avenues for glioblastoma

Scientists reveal structure of protein complex involved in liver and colon cancers

Study gives parents, doctors new options to treat children with eczema

Scientists release recommendations for evaluating pharmacological safety of oligonucleotide therapeutics

Skin cells possess olfactory receptor for sandalwood scent

Use of performance enhancing drugs unmonitored in young elite athletes

RD Biomed announces Chinese distribution agreement for reflux diagnostic tool Peptest

First Edition: July 8, 2014

Hypertension does not respond to therapy due to inadequate diagnosis

New mechanism of chemotherapy resistance in triple-negative inflammatory breast cancer

Alcohol ads can encourage kids to drink

Teen dating takes violent turn for nearly 1 in 6 young people

Reaction Biology awarded Phase I SBIR grant to create epigenetic database

CWRU receives $12.6 million from NIA to identify rare genetic variants that contribute to Alzheimer's

Sleep deprivation can lead a healthy person to display symptoms similar to schizophrenia

FDA grants Breakthrough Therapy status to Novartis' CTL019 for treatment of relapsed/refractory ALL

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News